iRhythm Holdings, Inc. - Common Stock (NQ:IRTC)

109.09 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about iRhythm Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

iRhythm Technologies Announces Third Quarter 2025 Financial Results

October 30, 2025

From iRhythm

Via GlobeNewswire

Earnings Scheduled For October 30, 2025 ↗

October 30, 2025

Via Benzinga

iRhythm Earnings: What To Look For From IRTC

October 28, 2025

Medical technology company iRhythm Technologies (NASDAQ:IRTC) will be announcing earnings results this Thursday after market close. Here’s what you need to know.

Via StockStory

3 Unprofitable Stocks We Find Risky

October 24, 2025

Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth.

Via StockStory

Halper Sadeh LLC Encourages iRhythm Technologies, Inc. Shareholders to Contact the Firm to Discuss Their Rights

October 23, 2025

From Halper Sadeh LLC

Via Business Wire

How Is The Market Feeling About iRhythm Technologies? ↗

September 18, 2025

Via Benzinga

Where iRhythm Technologies Stands With Analysts ↗

August 20, 2025

Via Benzinga

iRhythm Technologies to Report Third Quarter 2025 Financial Results on October 30, 2025

October 16, 2025

From iRhythm

Via GlobeNewswire

Forecasting The Future: 14 Analyst Projections For iRhythm Technologies ↗

October 13, 2025

Via Benzinga

Tesla To $300? Here Are 10 Top Analyst Forecasts For Monday ↗

October 13, 2025

Via Benzinga

What's Driving the Market Sentiment Around iRhythm Technologies Inc? ↗

October 08, 2025

Via Benzinga

Q2 Earnings Recap: iRhythm (NASDAQ:IRTC) Tops Patient Monitoring Stocks

October 05, 2025

Looking back on patient monitoring stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including iRhythm (NASDAQ:IRTC) and its peers.

Via StockStory

Topics Artificial Intelligence

2 Healthcare Stocks to Research Further and 1 Facing Challenges

October 03, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,...

Via StockStory

Topics Stocks

Centene, QuidelOrtho, iRhythm, and Bio-Techne Shares Skyrocket, What You Need To Know

October 02, 2025

A number of stocks jumped in the afternoon session after news of a new government prescription drug policy and a landmark deal with Pfizer eased investor concerns over stricter pricing regulations.

Via StockStory

Topics Government World Trade

IRHYTHM TECHNOLOGIES INC (NASDAQ:IRTC) Combines Technical Strength and Growth Momentum ↗

October 01, 2025

IRTC stock combines strong technical trends with accelerating fundamentals, aligning with Mark Minervini's high-growth strategy for potential continued gains.

Via Chartmill

1 Cash-Producing Stock with Competitive Advantages and 2 We Question

October 01, 2025

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak...

Via StockStory

Expert Outlook: iRhythm Technologies Through The Eyes Of 9 Analysts ↗

September 23, 2025

Via Benzinga

1 Growth Stock to Add to Your Roster and 2 We Brush Off

September 23, 2025

Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrained in investors who...

Via StockStory

IRHYTHM INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. – IRTC

September 18, 2025

From Kahn Swick & Foti, LLC

Via GlobeNewswire

3 Overrated Stocks with Open Questions

September 11, 2025

The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial...

Via StockStory

AMALFI Randomized Clinical Trial Results Demonstrate Increased Atrial Fibrillation Diagnosis with Home-Based Long-Term Continuous ECG Monitoring Using iRhythm Technologies’ Zio LTCM Service

August 29, 2025

From iRhythm

Via GlobeNewswire

3 Unprofitable Stocks We Steer Clear Of

August 21, 2025

Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth.

Via StockStory

iRhythm Technologies to Participate in Upcoming Investor Conferences

August 20, 2025

From iRhythm

Via GlobeNewswire

This Figma Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday ↗

August 20, 2025

Via Benzinga

Investor Short Report Flags Steep Downside Risk For iRhythm Technologies ↗

August 18, 2025

Spruce Point Capital warned iRhythm Technologies could face a 40%–70% stock decline, citing regulatory risks and product safety issues.

Via Benzinga

AVALON Real-World Evidence Builds on CAMELOT Study Reinforcing iRhythm’s Zio LTCM Clinical Superiority

August 18, 2025

From iRhythm

Via GlobeNewswire

Alignment Healthcare, Bio-Techne, Envista, iRhythm, and UFP Technologies Shares Skyrocket, What You Need To Know

August 13, 2025

A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer...

Via StockStory

Topics Economy

IRTC Q2 Deep Dive: Core Business Momentum and Product Expansion Shape Outlook

August 13, 2025

Medical technology company iRhythm Technologies (NASDAQ:IRTC) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 26.1% year on year to $186.7 million. The company’s...

Via StockStory

Topics Artificial Intelligence Economy

Tandem Diabetes, iRhythm, agilon health, Fortrea, and 10x Genomics Shares Skyrocket and Plummet, What You Need To Know

August 12, 2025

A number of stocks traded in opposite directions in the afternoon session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index...

Via StockStory

Topics Bonds Economy Stocks

3 Unpopular Stocks We Find Risky

August 07, 2025

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other...

Via StockStory

Topics Economy

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.